Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,928 articles
📰
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation...
Diversified Trust Co. Sells 7,280 Shares of Merck & Co., Inc. $MRK
Diversified Trust Co. lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.5% during the fourth quarter,...
Diversified Trust Co. Sells 7,280 Shares of Merck & Co., Inc. $MRK
Diversified Trust Co. lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.5% during the fourth quarter,...
Arm Holdings Stock Soars As Company Targets $15 Billion In Annual Sales From New In-House Chip
Arm Holdings Plc (NASDAQ:ARM) shares are surging in Tuesday’s after-hours session following reports that the company is targeting $15 billion...
📰
Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030
NASHVILLE, Tenn., March 24, 2026 (GLOBE NEWSWIRE) -- Harrow (NASDAQ:HROW), a leading provider of ophthalmic disease management solutions in North...
Braze Stock Shoots Higher After Q4 Revenue Surprises To Upside
Braze, Inc. (NASDAQ:BRZE) shares raced higher in Tuesday's extended trading after the company released its fourth-quarter earnings...
📰
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific...
📰
Is the Options Market Predicting a Spike in Bausch Health Stock?
Investors need to pay close attention to BHC stock based on the movements in the options market lately.
📰
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
Châtillon, France, March 24, 2026
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
Changes went into...
Dynamic Advisor Solutions LLC Sells 15,282 Shares of Abbott Laboratories $ABT
Dynamic Advisor Solutions LLC decreased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 33.8% during the 4th quarter, according to...
Dynamic Advisor Solutions LLC Sells 15,282 Shares of Abbott Laboratories $ABT
Dynamic Advisor Solutions LLC decreased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 33.8% during the 4th quarter, according to...
📰
Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
E. Ohman J or Asset Management AB Has $53.93 Million Holdings in Thermo Fisher Scientific Inc. $TMO
E. Ohman J or Asset Management AB decreased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 10.8% during...
Contravisory Investment Management Inc. Purchases 70,550 Shares of Merck & Co., Inc. $MRK
Contravisory Investment Management Inc. boosted its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 19,435.3% in the...
E. Ohman J or Asset Management AB Has $53.93 Million Holdings in Thermo Fisher Scientific Inc. $TMO
E. Ohman J or Asset Management AB decreased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 10.8% during...
Contravisory Investment Management Inc. Purchases 70,550 Shares of Merck & Co., Inc. $MRK
Contravisory Investment Management Inc. boosted its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 19,435.3% in the...
E. Ohman J or Asset Management AB Has $53.93 Million Holdings in Thermo Fisher Scientific Inc. $TMO
E. Ohman J or Asset Management AB decreased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 10.8% during...
Congress Asset Management Co. Has $121.09 Million Stock Position in Thermo Fisher Scientific Inc. $TMO
Congress Asset Management Co. raised its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 39.4% during the 4th quarter,...
Congress Asset Management Co. Has $121.09 Million Stock Position in Thermo Fisher Scientific Inc. $TMO
Congress Asset Management Co. raised its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 39.4% during the 4th quarter,...
Congress Asset Management Co. Has $121.09 Million Stock Position in Thermo Fisher Scientific Inc. $TMO
Congress Asset Management Co. raised its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 39.4% during the 4th quarter,...
📰
Integer Stock Down 28% as Insider Reports Sale. Here's What to Know
This contract manufacturer in medical devices reported a notable insider sale as it continues to serve global OEM customers.
📰
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
RARE DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines – RGNX
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
5,856 Shares in AbbVie Inc. $ABBV Acquired by Clear Trail Advisors LLC
Clear Trail Advisors LLC bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to its most recent...
5,856 Shares in AbbVie Inc. $ABBV Acquired by Clear Trail Advisors LLC
Clear Trail Advisors LLC bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to its most recent...
5,856 Shares in AbbVie Inc. $ABBV Acquired by Clear Trail Advisors LLC
Clear Trail Advisors LLC bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to its most recent...
📰
ROSEN, LEADING TRIAL ATTORNEYS, Encourages PomDoctor Ltd. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action - POM
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Picard Medical, Inc. of Class Action Lawsuit and Upcoming Deadlines – PMI
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
Best "Strong Buy" Momentum Stocks to Buy Now and in April
How investors can find the best "Strong Buy" momentum stocks to add to their portfolios heading into April and throughout 2026.
📰
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers – ATRA
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Sarepta to reveal first human data for two rare muscle disease drugs - Stock Titan
Sarepta to reveal first human data for two rare muscle disease drugs Stock Titan
📰
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
CAMBRIDGE, Mass., March 24, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today...
📰
Glass House Brands Reports Fourth Quarter and Full Year 2025 Financial Results
Fourth quarter and full year results reflect temporary planned scale back in wholesale production
At year-end was back to fully planted with legacy...